Publication of flu vaccines studies in prestigious journals are determined by the sponsor

Feb 13, 2009

Industry-sponsored studies on influenza vaccines are published in journals with higher rankings (impact factors) and are cited more than studies with other sponsors, but this is not because they are bigger or better, finds a study published on bmj.com today.

Tom Jefferson and colleagues at the Cochrane Vaccine Field in Italy identified and assessed 274 studies on influenza vaccines and analysed their methodological quality, prestige of the host journals (impact factor) and citation rates in the scientific literature.

They found no relationship between study quality, publication in prestige journals or their subsequent citation in other articles. They also found that influenza vaccine studies are of poor quality and those with conclusions in favour of the vaccines are of significantly lower methodological quality.

The single most important determinant of where the studies were published or how much they were cited was sponsorship. Those partially or wholly funded by industry had higher visibility.

The researchers also found no relationship between journal impact factor and the quality of the influenza vaccine studies it publishes, suggesting that the impact factor is not the robust quality indicator that publishers suggest and confirming some of the widely expressed doubts on its appropriateness as a means of rewarding researchers with promotions and funds.

Dr Jefferson concludes: "The study shows that one of the levers for accessing prestige journals is the financial size of your sponsor. Pharmaceutical sponsors order many reprints of studies supporting their products, often with in-house translations into many languages. They will also purchase publicity space on the journal. Many publishers openly advertise these services on their website. It is time journals made a full disclosure of their sources of funding."

Source: British Medical Journal

Explore further: New research demonstrates benefits of national and international device registries

add to favorites email to friend print save as pdf

Related Stories

Impoverished North Korea falls back on cyber weapons

4 hours ago

As one of the world's most impoverished powers, North Korea would struggle to match America's military or economic might, but appears to have settled on a relatively cheap method to torment its foe.

Five ways to make your email safer in case of a hack attack

4 hours ago

The Sony hack, the latest in a wave of company security breaches, exposed months of employee emails. Other hacks have given attackers access to sensitive information about a company and its customers, such as credit-card ...

Recommended for you

New approach to particle therapy dosimetry

Dec 19, 2014

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.